Clinical Trials in New York State

Showing 2401-2420 of 8,190 trials

BIOTRONIK Conduction System Pacing With the Solia Lead

NCT05251363

The purpose of the BIO-CONDUCT study is to demonstrate the safety and effectiveness of the BIOTRONIK Solia S pacing lead when implanted in the left bundle branch (LBB) area. Safety will be assessed by evaluating serious adverse device effects that occur through 3 months post-implant. Efficacy will be assessed by evaluating implant success rate.

BradycardiaAtrioventricular BlockLeft Bundle-Branch Block+1 more

Biotronik, Inc.194 participantsStarted Dec 2022

Phoenix, Arizona, United States • Ventura, California, United States • Washington D.C., District of Columbia, United States +11 more locations

COMPLETEDPhase 286 miles

Clinical Trial to Evaluate Safety and Efficacy of CCX168 in ANCA-Associated Vasculitis

NCT02222155

The aim of this trial is to test the safety and efficacy of two dose regimens of the complement C5a receptor CCX168 in patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). Funding Source - FDA OOPD

ANCA-associated Vasculitis

Amgen42 participantsStarted Feb 2015

Huntsville, Alabama, United States • Phoenix, Arizona, United States • Tucson, Arizona, United States +40 more locations

BIOTRONIK Conduction System Pacing With the Solia Lead

Clinical Trial to Evaluate Safety and Efficacy of CCX168 in ANCA-Associated Vasculitis

Find Trials by Condition in New York State

PF-06863135 As Single Agent And In Combination With Immunomodulatory Agents In Relapse/Refractory Multiple Myeloma

A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)

A Study of LY3561774 in Participants With Mixed Dyslipidemia

EVAS2 IDE Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory Study

Identifying Predictors of Poor Health-Related Quality-of-Life Among Pediatric Hematopoietic Stem Cell Donors

A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic Diseases

A Study of Etigilimab and Nivolumab in Participants With Locally Advanced or Metastatic Tumors

p53 Suppressor Activation in Recurrent High Grade Serous Ovarian Cancer, a Phase Ib/II Study of Systemic Carboplatin Combination Chemotherapy With or Without APR-246

Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA with High Risk T-Cell ALL & Lymphoma

Precision Study Measuring Potassium (K) in Capillary Specimens

Trial to Shorten Pharmacologic Treatment of Newborns With Neonatal Opioid Withdrawal Syndrome (NOWS)

Low Nicotine Content Cigarettes in Vulnerable Populations: Women of Reproductive Age

Valproic Acid and Carnitine in Patients With Spinal Muscular Atrophy

An Evaluation of LEO 138559 in Adults With Moderate to Severe Atopic Dermatitis.

Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5410 in Adult Participants 18 Years of Age and Older

Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT411

A Study to Evaluate the Safety of mRNA-0184 in Participants With Heart Failure

Pivotal, Clinical Study for the Accuracy Evaluation of the IdentiClone Dx TRG Assay